According to the Zhitong Finance App, Ruili Medical & Aesthetic (02135) announced interim results for the six months ended June 30, 2026. The group's revenue was RMB 115 million, up 35.67% year on year; profit attributable to shareholders was RMB 4.097 million, turning a year-on-year loss into a profit; profit per share was 0.74 points.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.